Evista (raloxifene hydrochloride)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Approval Status:

Approved September 1999

Specific Treatments:

For the treatment of osteoporosis in postmenopausal women.

Find Related Trials for The Following Conditions

General Information

Tablet of raloxifene hydrochloride for the treatment of osteoporosis in post-menopausal women.

Mechanism of Action

Tablet, 60 mg.